V.L.N. Murty

Columbia University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

26h-index2.3kcitations102works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glycosylation and Glycoproteins Research(49), Helicobacter pylori-related gastroenterology studies(30), Salivary Gland Disorders and Functions(30), Carbohydrate Chemistry and Synthesis(26), Microbial Metabolites in Food Biotechnology(16)

Publications102 total

Intrachromosomal rearrangement of chromosome 3q27: an under recognized mechanism of BCL6 translocation in B-cell non–Hodgkin lymphoma
Human Pathology·2006· 10 cited
Vector quantization of excitation gains in speech coding
Signal Processing·2001· 11 cited
Salivary mucins in oral mucosal defense
General Pharmacology The Vascular System·1996· 180 cited
Inhibition of gastric mucosal mucin receptor by H. pylori lipopolysaccharide: Effect of ebrotidine
General Pharmacology The Vascular System·1995
Gastric mucus viscosity and Helicobacter pylori.
Gut·1995· 2 citedOpen Access
Enhancement in gastric mucosal EGF and PDGF receptor expression with ulcer healing by sulglycotide
General Pharmacology The Vascular System·1995· 10 cited
Susceptibility of Helicobacter pylori to antimicrobial agents: effect of sulglycotide.
PubMed·1995· 4 cited
Helicobacter pylori aggregating activity of gastric mucin with ulcer healing by ebrotidine.
PubMed·1994· 2 cited
Inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide: Effect of sulglycotide
General Pharmacology The Vascular System·1994· 8 cited
Gastroprotective agents in mucosal defense against Helicobacter pylori
General Pharmacology The Vascular System·1994· 27 cited
Enhancement of gastric mucus phospholipid secretion by an antiulcer agent, ebrotidine
General Pharmacology The Vascular System·1994· 2 cited
Enhancement in gastric mucosal epidermal growth factor receptor expression by sulglycotide.
PubMed·1994· 2 cited
Association of salivary bacterial aggregating activity with sulfomucin.
PubMed·1994· 8 cited
Activation of arachidonoyl phospholipase A2 in prostaglandin-mediated action of sucralfate
General Pharmacology The Vascular System·1994· 12 cited
Inhibition of Helicobacter pylori glycosulfatase activity towards human gastric sulfomucin by a gastroprotective agent, sulglycotide
General Pharmacology The Vascular System·1993· 7 cited
Characterization of gastric mucosal mucin receptor.
PubMed·1993· 10 cited
Modulation of buccal mucosal calcium channel activity by salivary mucins.
PubMed·1993· 1 cited
Regulation of buccal mucosal calcium channel activity by salivary mucins
International Journal of Biochemistry·1993· 7 cited
Salivary and plasma insulin levels in man.
PubMed·1993· 23 cited
Modulation of gastric mucosal calcium channel activity by mucus glycoprotein
International Journal of Biochemistry·1993· 5 cited
page 1 of 6Next →

Frequent Co-authors

Bronislaw L. Slomiany(35), A. Slomiany(25), Amalia Slomiany(12), Irwin D. Mandel(11), Jerzy Sarosiek(9), J. Piotrowski(7), Jan Bilski(6), A Słomiany(5), M. Aono(5), Y.H. Liau(5), B.L. Slomiany(4), Krzysztof Gwoździński(3), Mitsuru Aono(3), Christine Nadziejko(3), M Kosmala(3), B. L. Slomiany(3), W Łaszewicz(3), K. VanHorn(2), J. Zieleński(2), E Zdebska(2)